GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Heartflow Inc
The value of HeartFlow, a privately held healthcare company, is determined by the extent of adoption of its non-invasive coronary heart disease diagnostic technology. The potential post-IPO share price will depend on insurance approvals and hospital partnerships.
Share prices of companies in the market segment - Heart
Heartflow, a company developing technology for non-invasive cardiac diagnostics, is valued in the private market based on its potential. We classify it as belonging to the cardiac technology sector, and the chart below illustrates the overall dynamics of this innovation-driven field.
Broad Market Index - GURU.Markets
HeartFlow is a medical technology company that has developed a non-invasive test for diagnosing coronary artery disease using CT scans. Its innovative approach makes it a prominent player in the GURU.Markets index. The chart below represents the entire market. Find out how HeartFlow compares to it.
Change in the price of a company, segment, and market as a whole per day
HTFL - Daily change in the company's share price Heartflow Inc
Shares of Heartflow, a company that creates 3D cardiac models for diagnostic purposes, are highly volatile. Change_co reflects sensitivity to news about the technology's implementation in clinics and insurance company decisions. This indicator is an important component of formulas on System.GURU.Markets that evaluate innovative companies in the MedTech sector.
Daily change in the price of a set of shares in a market segment - Heart
The medical technology sector in which Heartflow Inc operates is highly dynamic. This chart reflects the average volatility of the industry. It serves as a benchmark for assessing how sensitive Heartflow's cardiac diagnostics business is to overall trends and competition.
Daily change in the price of a broad market stock, index - GURU.Markets
Heartflow is a private company that has developed a non-invasive 3D coronary artery modeling technology. Its potential IPO will depend heavily on the market's appetite for medical technology innovation. The chart below shows the general volatility that influences the fate of such "unicorns."
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Heartflow Inc
Heartflow uses AI to analyze CT scans and diagnose coronary artery disease. This medtech company's stock reflects the growing role of AI in medicine. Its volatility is part of the dynamics of the innovative sector, which influences the entire market.
Annual dynamics of market capitalization of the market segment - Heart
HeartFlow, a privately held company, has revolutionized cardiac diagnostics with its non-invasive technology. Its growth, evident through hospital adoption, is likely significantly outpacing the medical device sector, as it offers a safer and less expensive alternative to traditional methods.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Heartflow is privately held and not publicly traded. Its market performance cannot be analyzed. Its business is non-invasive diagnostics for heart disease using artificial intelligence. This breakthrough technology, at the intersection of medicine and IT, targets the vast cardiology market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Heartflow Inc
Heartflow's performance as a medical diagnostics company will depend on the adoption of its technology. Monthly fluctuations on the chart will reflect the growing number of hospitals using its cardiac CT software and changes in insurance reimbursement policies.
Monthly dynamics of market capitalization of the market segment - Heart
Heartflow is developing a technology for non-invasive diagnosis of coronary heart disease based on CT data analysis. The company's commercial success depends on the widespread adoption of its technology in clinical practice. The dynamics of the medical technology sector will reflect the overall investor interest in healthcare innovation, which is an important backdrop for assessing Heartflow's prospects.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Heartflow Inc. has developed a non-invasive AI-based test for diagnosing coronary artery disease. This is a breakthrough technology in cardiology. Against the backdrop of market trends shown in the chart, Heartflow's performance is determined by the speed of adoption of its technology by doctors and insurance companies. Its history is a bet on changing medical standards, not economics.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Heartflow Inc
Heartflow, a cardiac diagnostics company, shares are highly volatile. Weekly price movements reflect news about the implementation of its technology in clinics, insurance company coverage decisions, and new research results. The chart below shows how short-term events in the medical imaging world affect the company's valuation.
Weekly dynamics of market capitalization of the market segment - Heart
How unique is Heartflow's performance in the MedTech sector? This chart compares the company's weekly stock price movements with the industry average. The analysis will reveal whether its movements are driven by unique news about the introduction of its cardiac diagnostic technology or whether it follows the general sentiment of medical startups.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Heartflow Inc. develops non-invasive heart disease diagnostic technology based on artificial intelligence. This chart compares its weekly performance with the market. It helps understand whether the stock is driven by the general technology trend or news about the clinical implementation of its technology.
Market capitalization of the company, segment and market as a whole
HTFL - Market capitalization of the company Heartflow Inc
Heartflow Inc.'s price chart reflects investors' bets on its breakthrough technology for noninvasive diagnosis of coronary heart disease. The company's market cap depends on how widely its CT scan analysis method is adopted by doctors and insurance companies. Its dynamics reflect hopes for a revolution in cardiology.
HTFL - Share of the company's market capitalization Heartflow Inc within the market segment - Heart
Heartflow Inc. is developing a technology for non-invasive diagnosis of coronary artery disease based on CT data analysis. Its share of the medical sector's market capitalization reflects the potential of its breakthrough technology. The chart shows how investors assess its potential to change the standards of cardiac diagnostics and achieve widespread adoption in clinics.
Market capitalization of the market segment - Heart
The chart below shows the total market capitalization of companies developing technologies for diagnosing heart disease. Heartflow is a pioneer in non-invasive coronary artery analysis. The dynamics in the chart reflect the enormous hopes for this technology, which could replace invasive diagnostics.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart shows the market valuation of the fight against the world's leading cause of death—heart disease. Heartflow's market cap reflects investors' faith in its non-invasive diagnostic technology. The line illustrates how innovations in cardiology are trying to capture their share of the vast global healthcare economy.
Book value capitalization of the company, segment and market as a whole
HTFL - Book value capitalization of the company Heartflow Inc
Heartflow, a medical imaging company, derives its book value from its technology capital. The chart below reflects the valuation of its unique software platform, which uses AI to analyze cardiac CT images, and its patents. The line's growth reflects investments in the development of this breakthrough noninvasive diagnostic tool.
HTFL - Share of the company's book capitalization Heartflow Inc within the market segment - Heart
For Heartflow, a medical imaging company, its physical assets aren't factories, but powerful computing centers for processing CT images and creating 3D cardiac models. The chart shows its share of physical assets, which reflects the scale of its expensive diagnostic technology infrastructure.
Market segment balance sheet capitalization - Heart
Heartflow Inc. is a company that creates 3D models of the heart. Its business isn't based on clinics, but on powerful supercomputers and data centers where CT data is processed. This is a "lightweight" model. The graph will show whether this focus on IT infrastructure is the norm for the medical diagnostics sector, or whether competitors are betting on hardware.
Book value of all companies included in the broad market index - GURU.Markets
Heartflow's assets are not hardware, but rather a unique AI-based technology that creates 3D models of the heart for non-invasive diagnostics. The book value reflects the capital invested in this revolutionary medical innovation, changing approaches to cardiology.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Heartflow Inc
Heartflow is a medical technology company that creates 3D models of the heart based on CT scans for the diagnosis of coronary heart disease. It has no tangible assets. Its entire value lies in its unique technology at the intersection of AI and medicine. The chart shows how the market perceives its product's potential to change the standards of cardiac diagnostics.
Market to book capitalization ratio in a market segment - Heart
Heartflow is a medical technology company that has developed a non-invasive method for diagnosing coronary heart disease. Its value lies in its unique technology and data, not its tangible assets. The chart shows how highly the market values this technology's potential to change the standards of cardiac diagnostics.
Market to book capitalization ratio for the market as a whole
HeartFlow Inc. develops a non-invasive diagnostic technology for heart disease based on CT data analysis. The chart shows how the market values this medical technology, which has the potential to change treatment standards. The company's market capitalization is not tied to its assets but rather reflects a bet on the widespread adoption of its technology by doctors and insurance companies worldwide.
Debts of the company, segment and market as a whole
HTFL - Company debts Heartflow Inc
Heartflow develops a technology for non-invasive diagnosis of coronary heart disease based on CT scan analysis. For a growth-stage medical technology company, debt can be a way to accelerate commercialization and expand its reach among clinics before reaching profitability, as demonstrated by the financial strategy in this chart.
Market segment debts - Heart
Heartflow is a medical technology company that has developed a non-invasive method for analyzing coronary arteries using CT data. This breakthrough technology requires investment for widespread clinical adoption. This chart shows the financial norms for the medical device sector, where companies are raising capital to commercialize their innovations.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Heartflow Inc
HeartFlow develops a non-invasive cardiovascular diagnostic technology based on CT data analysis. This is an innovative but highly capital-intensive area of MedTech. This chart shows how the company finances its expensive research and product commercialization, relying on equity or debt capital.
Market segment debt to market segment book capitalization - Heart
Heartflow Inc. develops a technology for non-invasive diagnostics of cardiovascular diseases based on CT data analysis. This chart compares the company's debt, raised to fund cutting-edge research and commercialization, to the total market capitalization of the entire cardiology sector. It reflects the financial stakes in the fight for heart health.
Debt to book value of all companies in the market
Heartflow Inc. is developing a breakthrough technology in cardiology. This chart compares the company's debt required for commercialization to the total book value of the entire economy. It demonstrates the financial resources required to implement medical innovations across the healthcare system.
P/E of the company, segment and market as a whole
P/E - Heartflow Inc
This metric for Heartflow Inc., a company offering non-invasive cardiac diagnostics, reflects investors' faith in its technology. For a company in the medical innovation sector, a high valuation may reflect expectations of widespread adoption of its method in clinical practice. The chart represents potential, not current profitability.
P/E of the market segment - Heart
This metric represents the average valuation for the medical technology sector in which Heartflow operates. In this innovative industry, the average valuation can be high, reflecting expectations for future growth. It provides context for understanding how the market values Heartflow's breakthrough cardiac diagnostic technology compared to other medical technology companies.
P/E of the market as a whole
Heartflow Inc. develops technology for non-invasive diagnosis of coronary heart disease. Using artificial intelligence to analyze CT data, the company helps doctors make more accurate decisions. This risk appetite chart helps understand how investors value innovative companies in the field of medical diagnostics.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Heartflow Inc
Heartflow Inc. is developing a non-invasive cardiovascular diagnostic technology based on CT data analysis. This chart reflects investor expectations for the widespread adoption of its technology in clinical practice. It demonstrates the market's belief that the company's innovative approach will change diagnostic standards in cardiology.
%20P%2FE%20Heartflow%20Inc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Heartflow-Inc&v=1772532987070 "Chart of the company's future (projected) P/E Heartflow Inc")
Future (projected) P/E of the market segment - Heart
HeartFlow is a digital healthcare company that has revolutionized the diagnosis of coronary artery disease. Its non-invasive technology creates a personalized 3D model of a patient's coronary arteries based on CT angiography data. This chart shows the average expectations for the medical technology sector, helping to appreciate HeartFlow's innovative approach to cardiology.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Heart&v=1772532987137 "Future (projected) P/E graph of the market segment - Heart")
Future (projected) P/E of the market as a whole
Heartflow Inc. is a medical technology company that has developed a non-invasive CT-based method for coronary artery analysis. Its growth depends on the adoption of this technology in clinical practice. This is a story about how innovation is changing medicine, and it is less dependent on the general economic cycles visible in the chart.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772532987191 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Heartflow Inc
HeartFlow Inc. is a medical technology company that offers a non-invasive method for diagnosing coronary artery disease using CT data analysis. Its revenue depends on physician adoption of this technology and insurance reimbursement. This chart shows how innovations in medical diagnostics are making their way into the market and impacting financial performance.
Profit of companies in the market segment - Heart
HeartFlow Inc. is a medical technology company offering a non-invasive method for diagnosing coronary artery disease based on CT imaging. This chart illustrates the profitability of the cardiology segment. HeartFlow's technology is changing diagnostic standards. Its growth depends on insurance company acceptance and clinical adoption, which could transform the entire sector.
Overall market profit
Heartflow Inc. has developed a noninvasive method for diagnosing coronary artery disease based on CT data analysis. The adoption of this technology in clinical practice depends on healthcare systems and their willingness to pay for innovation. This chart illustrates the overall economic trends against which Heartflow aims to change the standards of cardiac diagnostics.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Heartflow Inc
Heartflow Inc. is developing a non-invasive diagnostic technology for coronary artery disease based on CT data analysis. This chart reflects analysts' expectations for future profits, which depend on the speed of clinical adoption of this technology. It demonstrates the market's confidence that Heartflow will change the standard of cardiovascular disease diagnostics.
%20profit%20of%20the%20company%20Heartflow%20Inc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Heartflow-Inc&v=1772532987290 "Graph of future (projected) profit of the company Heartflow Inc")
Future (predicted) profit of companies in the market segment - Heart
HeartFlow Inc. has developed a non-invasive method for diagnosing coronary artery disease using CT data analysis and artificial intelligence. This chart shows profitability forecasts for the cardiology sector. It reflects expectations for the implementation of innovative diagnostic technologies that could change treatment standards.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Heart&v=1772532987361 "Graph of future (predicted) profits of companies in a market segment - Heart")
Future (predicted) profit of the market as a whole
Heartflow Inc. has developed a non-invasive method for diagnosing coronary artery disease based on CT scan analysis. The adoption of such innovations depends on the healthcare system's willingness to pay for them. The positive corporate profit forecast reflected here indirectly impacts hospital budgets, allowing them to invest in advanced technologies that improve diagnostics and save lives.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772532987399 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Heartflow Inc
Heartflow Inc. develops a technology for non-invasive diagnostics of cardiac diseases based on CT scan analysis. For a growth-stage medical technology company, the P/S ratio is a key metric. It reflects how investors assess the potential of its technology to change the standards of cardiac diagnostics and capture the market.
P/S market segment - Heart
HeartFlow Inc. has developed a non-invasive technology that creates a 3D model of a patient's coronary arteries based on CT scan data, helping doctors diagnose coronary artery disease. Their revenue depends on the implementation of this technology in hospitals. The chart shows how the market perceives the potential of their innovative approach to diagnosing heart disease.
P/S of the market as a whole
Heartflow has developed a non-invasive CT data analysis technology for diagnosing coronary artery disease. The company's revenue depends on the adoption of this technology in clinical practice. This chart illustrates the average revenue estimate, which helps understand the market's valuation premium for innovation and the potential to change medical standards.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Heartflow Inc
Heartflow is developing a technology for non-invasive diagnosis of coronary heart disease based on CT scan analysis. This chart reflects investor expectations for future revenue from the implementation of its technology in hospitals, which could change diagnostic standards and reduce the number of invasive procedures, creating a huge potential market.
%20P%2FS%20Heartflow%20Inc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Heartflow-Inc&v=1772532987520 "The graph of the company's future (projected) P/S Heartflow Inc")
Future (projected) P/S of the market segment - Heart
Heartflow Inc. is developing a non-invasive diagnostic technology for coronary artery disease using artificial intelligence to analyze CT data. This chart shows how the market assesses the future potential of its technology for clinical adoption compared to other companies in the cardiology sector. This assessment depends on the pace of physician adoption of its innovation.
%20P%2FS%20market%20segment%20graph%20-%20Heart&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Heart&v=1772532987649 "Future (projected) P/S market segment graph - Heart")
Future (projected) P/S of the market as a whole
Heartflow is a company that has developed a non-invasive method for analyzing coronary arteries using CT data. Its technology has the potential to transform the diagnosis of heart disease. This chart reflects overall revenue projections, and Heartflow illustrates how breakthrough medical technologies can create new markets and treatment standards, raising investor expectations.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772532987672 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Heartflow Inc
HeartFlow Inc. is a company developing a non-invasive diagnostic technology for coronary artery disease. Its software creates a 3D model of the coronary arteries based on CT scan data. Revenue, as shown in the graph, is generated by a fee for each analysis performed. Sales growth depends on the adoption of this technology by cardiologists and insurance companies.
Sales of companies in the market segment - Heart
Heartflow is developing a unique technology for non-invasive diagnosis of coronary heart disease. Currently, its revenue can be derived from payments for each diagnostic performed. This graph allows investors to track the growth in the number of procedures, which is a direct indicator of the adoption of its innovative technology in medical practice.
Overall market sales
Heartflow Inc. is developing a technology for non-invasive diagnosis of coronary heart disease. The company's growth depends on the acceptance of its technology by physicians and insurance companies. General economic cycles, as shown in this chart, are not a determining factor for Heartflow. The company's primary focus is on demonstrating the clinical and cost effectiveness of its product.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Heartflow Inc
Heartflow Inc. has developed a non-invasive method for diagnosing coronary artery disease based on CT data analysis. Its revenue forecast depends on the widespread adoption of this technology in medical institutions. This chart shows how analysts estimate the rate of adoption of its innovative approach in cardiology practice.
%20sales%20of%20the%20company%20Heartflow%20Inc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Heartflow-Inc&v=1772532987901 "Schedule of future (projected) sales of the company Heartflow Inc")
Future (projected) sales of companies in the market segment - Heart
Heartflow Inc. has developed a non-invasive technology for diagnosing coronary artery disease. This chart shows projected revenue for the cardiology segment. It helps assess how quickly analysts expect the medical community to adopt new diagnostic methods, which is critical for the commercialization of Heartflow's technology.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Heart&v=1772532987917 "Schedule of future (projected) sales of companies in the market segment - Heart")
Future (projected) sales of the market as a whole
Heartflow is a medical technology company that has developed a non-invasive method for coronary artery analysis. Demand for its services depends on the implementation of new technologies in cardiology and hospital budgets. The overall economic situation, shown in the graph, influences healthcare system funding, which is a key factor in the widespread adoption of innovative diagnostic methods.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772532987952 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Heartflow Inc
Heartflow Inc. has developed a non-invasive technology for diagnosing coronary artery disease. This chart shows the financial trajectory of the medical innovation company. Its ability to achieve profitability depends on widespread adoption of its technology in clinical practice and insurance reimbursement for the analysis.
Market segment marginality - Heart
HeartFlow offers noninvasive diagnostic technology for coronary artery disease based on CT scan analysis. This chart illustrates the commercial potential of this revolutionary technology. Its future high profitability will demonstrate its clinical value, acceptance by the medical community, and potential to reduce healthcare costs.
Market marginality as a whole
Heartflow Inc. is developing a technology for non-invasive diagnosis of coronary artery disease based on CT imaging analysis. The company aims to change the standards of cardiac diagnostics. This graph shows the profitability of existing markets, while Heartflow is creating an entirely new market, where success depends on the adoption of the technology by the medical community.
Employees in the company, segment and market as a whole
Number of employees in the company Heartflow Inc
HeartFlow provides non-invasive technology for coronary artery analysis based on CT data. Its team consists of IT specialists, analysts, and clinicians. The growth in this graph reflects the expansion of its technology in hospitals and investments in artificial intelligence to improve cardiovascular disease diagnostics.
Share of the company's employees Heartflow Inc within the market segment - Heart
HeartFlow Inc. has developed a non-invasive technology that helps diagnose coronary artery disease by analyzing CT data. This chart illustrates its innovative contribution to cardiology. It reflects the proportion of data analysts, artificial intelligence specialists, and clinicians working at the intersection of IT and medicine that HeartFlow brings together.
Number of employees in the market segment - Heart
Heartflow Inc. is developing a non-invasive diagnostic technology for coronary artery disease based on CT data analysis. This chart illustrates employment in the cardiology and medical technology sector. Growth in this advanced field reflects the shift toward personalized and preventative medicine, creating a huge market for Heartflow's innovative diagnostic tools.
Number of employees in the market as a whole
Heartflow Inc. has developed a technology for non-invasive diagnosis of coronary heart disease. The growth of its sales and clinical support team reflects the adoption of advanced medical technologies in hospitals. This is an example of how innovations in medical technology not only save lives but also create new highly skilled jobs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Heartflow Inc (HTFL)
Heartflow is a company that has developed a non-invasive CT-based method for coronary artery analysis. Their product is a service based on sophisticated software and data analysis. This chart shows that they are a knowledge-intensive IT business. The market values their technology highly, allowing a small team of analysts and engineers to generate enormous value.
%20of%20the%20company%20Heartflow%20Inc%20(HTFL)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Heartflow-Inc-HTFL&v=1772532988567 "Chart of market capitalization per employee (in thousands of dollars) of the company Heartflow Inc (HTFL)")
Market capitalization per employee (in thousands of dollars) in the market segment - Heart
Heartflow is a medical technology company that has developed a non-invasive CT-based test for diagnosing coronary artery disease. Its value lies in its unique technology and software. This chart shows the industry average, helping to estimate the market value generated by this innovative diagnostic platform per employee.
%20by%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Heart&v=1772532988615 "Market capitalization per employee (in thousands of dollars) by market segment - Heart")
Market capitalization per employee (in thousands of dollars) for the overall market
Heartflow Inc. is developing a non-invasive diagnostic technology for coronary heart disease using artificial intelligence to analyze CT data. This is a breakthrough medical technology. This chart reflects the enormous investor expectations for the ability of this small team of scientists and engineers to revolutionize the approach to cardiac diagnosis.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772532988710 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Heartflow Inc (HTFL)
Heartflow Inc. develops a non-invasive cardiovascular diagnostic technology using AI to analyze CT scans. It's a high-tech medical software-as-a-service (SaaS). This graph, likely negative, shows how much the company is investing in R&D, sales, and approvals to implement its technology in hospitals.
%20Chart%20Heartflow%20Inc%20(HTFL)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Heartflow-Inc-HTFL&v=1772532988775 "Company Profit Per Employee (in thousands of dollars) Chart Heartflow Inc (HTFL)")
Profit per employee (in thousands of dollars) in the market segment - Heart
Heartflow is a "SaaS diagnostics" service. They use AI to create 3D models of the heart (from CT scans) to avoid invasive diagnostics. This graph shows the benchmark for "Med-IT." In this SaaS sector, the benchmark (for a company to be profitable) must be high. Revenue per employee is generated by the "fee" for each "analysis" performed by the AI.
%20in%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Heart&v=1772532988937 "Chart of profit per employee (in thousands of dollars) in the market segment - Heart")
Profit per employee (in thousands of dollars) for the market as a whole
Heartflow is a digital medicine company. They have developed a non-invasive AI-powered test (FFRct) that creates a 3D model of the heart from CT scan data for diagnosing coronary heart disease. This is MedTech R&D. This metric, which illustrates the average profitability per employee in the economy, begs the question: how does the AI diagnostics sector, like Heartflow, compare to average profitability?
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772532989033 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Heartflow Inc (HTFL)
Heartflow Inc. is a company that has developed a non-invasive diagnostic technology for coronary heart disease. This graph reflects the commercialization stage of this medical innovation. Increased revenue per employee will indicate successful implementation of the technology in clinical practice and recognition of its value by physicians and insurance companies.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Heartflow-Inc-HTFL&v=1772532989070 "Sales chart per company employee Heartflow Inc (HTFL)")
Sales per employee in the market segment - Heart
Heartflow offers a unique service: non-invasive CT scan analysis for heart disease diagnosis using AI. It's a hybrid of SaaS and medtech. This chart shows the average revenue per employee in the segment. It helps evaluate how effectively the Heartflow team (R&D, sales) monetizes its technology compared to competitors.
Sales per employee for the market as a whole
Heartflow (HTFL) is a medical IT company providing CT-based 3D cardiac modeling technology (for diagnosing coronary artery disease). It's a SaaS business in the medical field. This metric measures how successfully the company sells its tests (services). Growth means that more and more hospitals are adopting their technology, and the platform's revenue is growing faster than its staff.
Short shares by company, segment and market as a whole
Shares shorted by company Heartflow Inc (HTFL)
Heartflow Inc. is developing a non-invasive AI-based test for diagnosing cardiovascular disease (CT scan analysis). This technology is promising. This chart shows high skepticism. Bears doubt the company will be able to convince insurance companies to cover this test en masse, or that its technology will be inaccurate.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Heartflow-Inc-HTFL&v=1772532989124 "Short Shares Chart for the Company Heartflow Inc (HTFL)")
Shares shorted by market segment - Heart
Heartflow Inc. is developing AI-based technology for non-invasive diagnosis of coronary artery disease using CT scans. This chart highlights the pessimism in the IT healthcare sector. The increase in short positions across the industry may indicate that investors doubt insurance companies will actively cover the costs of this new technology, which will slow its adoption in clinics.
Shares shorted by the overall market
Heartflow Inc. is developing a non-invasive cardiovascular diagnostic technology using artificial intelligence to analyze CT scans. This chart reflects the overall level of investor fear. For an innovative medical company still struggling to achieve widespread adoption, market pessimism is dangerous. It could force hospitals to cut budgets for new technologies, favoring proven diagnostic methods.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Heartflow Inc (HTFL)
Heartflow provides a CT-based, non-invasive technology for diagnosing coronary artery disease. Business depends on technology adoption and insurer reimbursement. A chart above 70 may reflect positive reimbursement news or an increase in the number of procedures. A chart below 30 indicates slow adoption or payment issues.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Heartflow-Inc-HTFL&v=1772532989416 "RSI 14 indicator chart for the company's stock Heartflow Inc (HTFL)")
RSI 14 Market Segment - Heart
Heartflow Inc. is a medical technology company that has revolutionized the diagnosis of coronary artery disease. Its non-invasive CT-based analysis creates a 3D model of the heart. This graph tracks the collective momentum in the cardiovascular medical technology sector. It helps understand whether the HTFL trend is unique or reflects a general "overheating" in the medical technology sector.
RSI 14 for the overall market
Heartflow (HTFL) provides software for non-invasive cardiac diagnostics. This graph reflects hospitals' willingness to implement expensive innovations. During periods of euphoria and budget increases, clinics eagerly purchase new technologies. During times of panic and cost-cutting, they may postpone HTFL implementation in favor of cheaper, standard tests.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast HTFL (Heartflow Inc)
Heartflow (HTFL) is a medical technology company that has developed a noninvasive CT-based test for diagnosing coronary artery disease. This software helps doctors assess arterial blockages. The chart shows the analyst consensus forecast, which shows their assessment of the speed of physician adoption and reimbursement from insurance companies.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-HTFL-Heartflow-Inc&v=1772532989636 "A chart showing analyst consensus forecasts for the expected stock price. HTFL (Heartflow Inc)")
The difference between the consensus estimate and the actual stock price HTFL (Heartflow Inc)
Heartflow is a medical technology company that uses AI and CT scan data to create 3D models of the heart. This helps doctors non-invasively diagnose coronary heart disease. This chart shows the difference between the market's current valuation of the company and the analyst consensus target. This reflects their confidence in the implementation of this technology in clinics.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-HTFL-Heartflow-Inc&v=1772532989732 "A chart showing the difference between the consensus forecast and the actual stock price. HTFL (Heartflow Inc)")
Analyst consensus forecast for stock prices by market segment - Heart
Heartflow is a digital healthcare company. It has developed a noninvasive CT-based test that creates a 3D model of the heart and helps detect coronary artery disease. This chart shows general expectations for the cardiology sector. It reflects whether experts believe in the implementation of smart diagnostics in cardiology.
Analysts' consensus forecast for the overall market share price
Heartflow (HTFL) is a MedTech company. They use AI to create a 3D model of the heart from CT scans, helping to avoid invasive diagnostics. This is an R&D project. This graph, reflecting expert expectations, influences them. In a recession (pessimism), insurers (payers) are reluctant to approve new, expensive, albeit innovative tests.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Heartflow Inc
Heartflow is a digital medicine company that has revolutionized cardiology. Their software creates a 3D model of the heart based on CT scans, allowing doctors to non-invasively assess arterial blockages. This graph is an indicator of technology adoption. It likely aggregates the number of tests performed and, crucially, their success in obtaining reimbursement from insurance companies.
AKIMA Market Segment Index - Heart
Heartflow is a medtech innovator in cardiology; the company has created unique software (SaaS) that (using AI and CT scans) creates a 3D model of the heart and identifies blockages without invasive surgery. This aggregate metric evaluates companies. The graph shows the sector average. This benchmark: how does Heartflow's breakthrough (AI) diagnostic model differentiate it from the average medtech competitor?
The AKIM Index for the overall market
Heartflow is revolutionizing cardiology. The company uses AI to create 3D models of the heart (based on CT scans), helping to avoid invasive diagnostics. This is a breakthrough technology. This chart, reflecting the market average, is just the background. It helps assess how this innovative MedTech story fits in with overall economic trends.
